Literature DB >> 6979551

Normal serum 1,25-dihydroxyvitamin D in patients with medullary carcinoma of the thyroid.

S Lee, S Morimoto, T Onishi, M Tsuji, Y Okada, Y Seino, M Ishida, K Yamaoka, S Takai, A Miyauchi, Y Kumahara.   

Abstract

Serum calcium, phosphorus, calcitonin, parathyroid hormone, 25-hydroxyvitamin D (25OHD), and 1,25-dihydroxyvitamin D [1,25-(OH)2D] were measured in 6 women and 2 men with medullary carcinoma of the thyroid, 22 normal subjects, 5 patients with chronic renal failure, and 5 patients with primary hyperparathyroidism. Serum 1,25-(OH)2D levels were significantly higher in patients with primary hyperparathyroidism and lower in patients with chronic renal failure than in normal subjects. In patients with medullary carcinoma of the thyroid, the serum calcitonin levels were elevated, but the parathyroid hormone and 1,25-(OH)2D levels were within normal ranges. The serum 25OHD levels were not significantly different in any group. It is concluded that chronic elevation of serum calcitonin has no effect on the serum 1,25-(OH)2D level.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6979551     DOI: 10.1210/jcem-55-2-361

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Effect of 1 alpha-hydroxycholecalciferol on psoriasis vulgaris: a pilot study.

Authors:  S Takamoto; T Onishi; S Morimoto; S Imanaka; S Yukawa; T Kozuka; Y Kitano; Y Seino; Y Kumahara
Journal:  Calcif Tissue Int       Date:  1986-12       Impact factor: 4.333

2.  Treatment of psoriasis vulgaris by oral administration of 1 alpha-hydroxyvitamin D3--open-design study.

Authors:  S Morimoto; K Yoshikawa; T Kozuka; Y Kitano; S Imanaka; K Fukuo; E Koh; T Onishi; Y Kumahara
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

3.  Topical administration of 1,25-dihydroxyvitamin D3 for psoriasis: report of five cases.

Authors:  S Morimoto; T Onishi; S Imanaka; H Yukawa; T Kozuka; Y Kitano; K Yoshikawa; Y Kumahara
Journal:  Calcif Tissue Int       Date:  1986-02       Impact factor: 4.333

4.  The vitamin d receptor in thyroid development and function.

Authors:  Isabelle Clinckspoor; Anne-Catherine Gérard; Jacqueline Van Sande; Marie-Christine Many; Lieve Verlinden; Roger Bouillon; Geert Carmeliet; Chantal Mathieu; Annemieke Verstuyf; Brigitte Decallonne
Journal:  Eur Thyroid J       Date:  2012-09-22

5.  Prospective Study of Ultraviolet Radiation Exposure and Thyroid Cancer Risk in the United States.

Authors:  Rachel D Zamoiski; Elizabeth K Cahoon; D Michal Freedman; Martha S Linet; Cari M Kitahara
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-02       Impact factor: 4.254

6.  Effect of ipriflavone on bone mineral density and calcium-related factors in elderly females.

Authors:  S Nakamura; S Morimoto; S Takamoto; T Onishi; K Fukuo; E Koh; S Kitano; Y Miyashita; O Yasuda; M Tamatani
Journal:  Calcif Tissue Int       Date:  1992       Impact factor: 4.333

7.  Evidence that calcitonin plays a role in the postnatal increase of serum 1 alpha,25-dihydroxyvitamin D.

Authors:  T Nishioka; T Yasuda; H Niimi; H Nakajima
Journal:  Eur J Pediatr       Date:  1988-02       Impact factor: 3.183

Review 8.  The Controversial Role of Vitamin D in Thyroid Cancer Prevention.

Authors:  Ana Palanca; Francisco Javier Ampudia-Blasco; José T Real
Journal:  Nutrients       Date:  2022-06-23       Impact factor: 6.706

9.  Potential Use of 1-25-dihydroxyvitamin D in the Diagnosis and Treatment of Papillary Thyroid Cancer.

Authors:  Ting Zhang; Hao Zhang; Liang He; Zhihong Wang; Wenwu Dong; Wei Sun; Ping Zhang
Journal:  Med Sci Monit       Date:  2018-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.